By proceeding, you agree to our Terms of Use and Privacy Policy.
Dedicated to driving cost-effective, efficacious, safe, durable, scalable, and globally accessible allogeneic, cell-based, and engager therapies, the 8th Innate Killer Summit returns to cement your end-to-end education in innate immune therapeutics.
Network with leading experts and professionals from the healthcare industry through sessions.
Discover novel engineering technologies and LNP delivery methods, providing an end-to-end discovery through CMC & clinical development overview.
Deep-dive into memory phenotypes, mechanisms of action, and strategies to drive long-term memory formation to product persistent responses.
Explore cutting-edge breakthroughs to improve the efficacy of NK, gdT and NKT cell therapy for patients in need.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
LUMICKS is the leading supplier of Dynamic Single-Molecule and Cell Avidity analysis instruments.
An innovative biotechnology company focused on providing its worldwide customers the best-in-class raw materials and components for superior research and product development.
Be The Match BioTherapies® partners with organizations pursuing life-saving cellular therapies in every stage of development – from discovery through commercialization.
Affimed (Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer.
ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf.
For over 30 years, Miltenyi Biotec has been a major provider of products and services that drive biomedical research and boost cell and gene therapy.
GemPharmatech Co. Ltd., founded in 2017, is an international biotechnology enterprise specializing in the development of humanized animal models. The management and operation team has nearly 20 years of experience in gene-editing technology and anima
GemPharmatech Co. Ltd., founded in 2017, is an international biotechnology enterprise specializing in the development of humanized animal models. The management and operation team has nearly 20 years of experience in gene-editing technology and animal production. GemPharmatech provides a one-stop se
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.